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The hippocampus is a complex network tightly regulated by interactions between excita-
tory and inhibitory neurons. In neurodegenerative disorders where cognitive functions
such as learning and memory are impaired this excitation-inhibition balance may be
altered. Interestingly, the uncompetitive N -methyl-d-aspartate receptor (NMDAR) antago-
nist memantine, currently in clinical use for the treatment of Alzheimer’s disease, may alter
the excitation-inhibition balance in the hippocampus. However, the specific mechanism by
which memantine exerts this action is not clear. To better elucidate the effect of meman-
tine on hippocampal circuitry, we studied its pharmacology on NMDAR currents in both
pyramidal cells (PCs) and interneurons (Ints) in the CA1 region of the hippocampus. Apply-
ing whole-cell patch-clamp methodology to acute rat hippocampal slices, we report that
memantine antagonism is more robust in PCs than in Ints. Using specific NMDAR subunit
antagonists, we determined that this selective antagonism of memantine is attributable to
specific differences in the molecular make-up of the NMDARs in excitatory and inhibitory
neurons. These findings offer new insight into the mechanism of action and therapeutic
potential of NMDA receptor pharmacology in modulating hippocampal excitability.
Keywords: NMDA receptor, NMDA receptor antagonists, electrophysiology, excitatory transmission, hippocampal
neurons, memantine
INTRODUCTION
While the pathogenesis of neurodegenerative diseases remains
poorly understood, the involvement of the glutamatergic system
and, specifically, of the N -methyl-d-aspartate receptor (NMDAR)
in the pathogenesis of numerous neurodegenerative disorders is
widely recognized (Hardingham and Bading, 2010).
N -Methyl-d-aspartate receptor are heteromultimeric channels
comprised of three different subunit families (NR1, NR2A-D,
NR3A-B; Meguro et al., 1992; Monyer et al., 1992; Dingledine et al.,
1999). Different combinations of these subunits confer the phar-
macological profile, gating properties, and Mg2+ sensitivity to the
NMDAR complex (Sucher et al., 1995; Danysz and Parsons, 1998).
Because of their properties, NMDARs are important to fast synap-
tic neurotransmission and synaptic plasticity (Cull-Candy et al.,
2001). NMDAR activation requires the presence of glutamate and
a co-agonist (glycine or d-serine) as well as the relief of the Mg2+
block through depolarization (Danysz and Parsons, 1998). Once
open, NMDARs allow the passage of Ca2+ and, to a lesser extent,
Na+ and K+ (fast synaptic transmission). Ca2+ influx through the
NMDAR is also responsible for the persistent changes observed in
long-term potentiation (LTP), the cellular mechanism underlying
synaptic plasticity (Nicoll and Malenka, 1999; Cull-Candy et al.,
2001), which is implicated in cognitive functions such as learning
and memory.
One of the most devastating symptoms associated with neu-
rodegenerative disorders is cognitive impairment, and damage to
the hippocampal formation, the principal region associated with
learning and memory, is linked to these disorders. The hippocam-
pus is a complex network that consists of tightly regulated inter-
actions between excitation [glutamatergic dentate granular cells,
CA1, and CA3 pyramidal cells (PCs)] and inhibition [GABAergic
interneurons (Ints); Woodson et al., 1989]. Inhibitory Ints play
a crucial role in regulating the interactions between PCs (Klaus-
berger et al., 2005; Klausberger and Somogyi, 2008; Isaacson and
Scanziani, 2011; Kullmann, 2011), including population oscilla-
tions, plasticity, epileptic synchronization, hormonal effects, and
cortical development. Palop and Mucke (2010) suggested that
in Alzheimer’s disease (AD), dysfunction of Ints likely increases
synchrony among excitatory principal cells and contributes to
the destabilization of neuronal networks. In addition, using ani-
mal model studies, it has been hypothesized that in AD, the
excitation-inhibition balance in hippocampal neuronal circuitry is
shifted, resulting in over-excitation (Schmitt, 2005). Furthermore,
memantine, an uncompetitive NMDAR antagonist clinically used
for the treatment of mild to severe AD (2003 EU, USA), may restore
balance between excitation and inhibition (Schmitt, 2005; Parsons
et al., 2007). Very recently, Guadagna et al. (2012) suggested that,
in mice, clinically relevant doses of memantine promote neuronal
network synchronization in the hippocampus.
To elucidate the mechanisms by which memantine preserves
basal synaptic activity and inhibits excitotoxicity in the AD brain,
its pharmacology has been studied extensively (for a review see Par-
sons et al., 2007). Memantine is a use-dependent NMDAR antag-
onist (open-channel blocker). Its primary binding site overlaps
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that of Mg2+ (Kashiwagi et al., 2002; Chen and Lipton, 2005),
it has low-affinity for the NMDAR, it has relatively rapid on-
off binding kinetics, and it exhibits partial trapping (Parsons
et al., 1995; Mealing et al., 1999). Collectively, these properties
can be extrapolated to partially explain memantine’s modula-
tion of hippocampal activity. However, pharmacological studies
to date have been conducted using cultured cortical neurons or
using NMDARs expressed in cell lines, but have not considered
the effect of memantine on native synaptic NMDARs in excitatory
and inhibitory neurons incorporated into physiological neuronal
networks. To address this limitation, we performed whole-cell
patch-clamp on acute rat hippocampal brain slices and studied
the effect of memantine on NMDARs in PCs and Ints. We found
that memantine antagonism of NMDAR currents was more robust
in PCs than in Ints at low concentrations (0.1–1µM), while it
was comparable at concentrations higher than 1µM. Using phar-
macological blockage of specific NMDAR subunits, we found
that memantine antagonism is dependent upon on the molecular
make-up of the NMDAR that different neuronal types express.
MATERIALS AND METHODS
This study was approved by the Animal Care Committee of the
National Research Council of Canada.
PREPARATION OF HIPPOCAMPAL SLICES
Coronal brain slices containing the hippocampus were obtained
from 21- to 28-day-old Sprague–Dawley rats. Prior to decapita-
tion, animals were anesthetized with isofluorane (4%, 2 L/min O2
flow rate), in conformity with the guidelines of the Canadian
Council of Animal Care. The brain was removed and placed in
an oxygenated (95% O2/5% CO2) physiological solution, artificial
cerebrospinal fluid (ACSF), at 4˚C containing (mM) 126 NaCl, 2.5
KCl, 1 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 ascorbic
acid, and 10 glucose (300 mOsm, pH= 7.3).
A tissue block containing the hippocampal region of interest
was sectioned into 300µm thick slices using a vibrating micro-
tome (Vibratome Series 300, Vibratome, Bannockburn, IL, USA).
Slices were incubated in an oxygenated submersion chamber at
room temperature for a minimum of 1 h prior to recording.
DATA RECORDING AND ANALYSIS
Voltage-clamp experiments were performed at room temper-
ature using borosilicate pipettes filled with a pipette solu-
tion containing (in mM) 130 Cs+-methanesulfonate, 10 N -
2-hydroxy-ethylpiperazine- N ′-2-ethanesulfonic acid (HEPES),
10 CsCl, 2 MgCl2, 2 ATP-Mg, 0.2 GTP-tris(hydroxy-
methyl)aminomethane, 5 lidocaine N -ethylbromide (QX-314),
5 1,2-bis(o-aminophenoxy)ethane-N,N,N ′,N ′-tetraacetic acid;
BAPTA). The pH was adjusted to 7.2 with CsOH and osmolarity
was adjusted to 280–290 mOsm. The liquid junction potential was
measured (∼10 mV) and membrane potential (Vm) was corrected
accordingly. Pipettes had a resistance of 3–5 MΩ. Whole-cell access
resistance ranged from 5 to 15 MΩ and was monitored throughout
the experiments.
Recordings were obtained from PCs and Ints in the stra-
tum pyramidale and stratum radiatum of the CA1 region of
the hippocampus, respectively (Figure 1; also see Discussion).
We recorded from Ints located ∼250–300µm from the stratum
pyramidale. Following the interneuron classification (Klausberger,
2009), we suggest that the Ints we recorded were Schaffer collateral-
associated cells and/or apical dendrite innervating cells which
express cholecystokinin (i.e., CCK-expressing Ints; Klausberger,
2009). The soma of Schaffer collateral-associated cells is located
mainly in stratum radiatum with dendrites spanning all layers
(Figure 1). The axons of these cells innervate the oblique and to a
lesser extent basal dendrites of CA1 PCs and Ints mainly in stra-
tum radiatum (Klausberger, 2009). Apical dendrite innervating
cells have soma, dendritic, and axonal distributions very similar to
those of Schaffer collateral-associated cells (Figure 1). However,
electron microscopic investigations have indicated that the apical
dendrite-targeting cells innervate preferentially the main apical
shaft of CA1 PCs (Klausberger et al., 2005).
Whole-cell patch-clamp recordings were acquired using a Mul-
ticlamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA)
under visual control using differential interference contrast and
infrared video microscopy (IR-DIC; Olympus BX50WI; Olympus
Canada, Inc., Markham, ON, Canada). Whole-cell currents were
recorded from individual PCs and Ints voltage-clamped at −70
and−30 mV.
Post-synaptic responses were evoked by electrical stimulation
of the Schaffer collaterals with a bipolar microelectrode positioned
in the stratum radiatum. Stimulation, consisting of 300µs uration
current pulses (0.1–1 mA; 0.1 Hz), was adjusted to evoke EPSC
amplitudes in the range of 60–120 pA at Vm=−70 mV in ACSF.
To isolate the NMDAR-mediated component of evoked
responses we used normal ACSF (at −30 mV) or ACSF con-
taining a low concentration of MgCl2 (0.1 mM) with osmolarity
maintained by CaCl2 (at−70 mV), and the 2-amino-3-(5-methyl-
3-oxo-1,2- oxazol-4-yl)propanoic acid receptor (AMPAR) antago-
nist 1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxaline-7-
sulfonamide (NBQX, 20µM), the GABAA receptor antagonist
picrotoxin (50µM), and the GABAB receptor antagonist 3-[[(3,4-
dichlorophenyl)methyl]amino]propyl]diethoxymethyl)phosphinic
acid (CGP 52432, 10µM; Martina et al., 2003).
One pitfall with the patch-clamp technique is the distortion of
voltage-gated currents from neurons in brain slices due to non-
uniform space-clamp control. To reduce current attenuation due
to space-clamp that can occur when recording voltage-gated cur-
rents from neurons in brain slices, we recorded the CA1 neurons
using a pipette solution containing Cs2+ and QX-314, to block
K+ and Na2+ conductances. The additional blockage of AMPAR,
GABAA receptor, and the GABAB receptor further reduced space-
clamp attenuation. We also tried to obtain recordings with very
low series resistances and compensate them as much as possi-
ble (90%). Attention was also given to the shape of the evoked
responses during off-line analysis (Williams and Mitchell, 2008).
Collectively, these measures ensured that space-clamp errors were
minimal.
To isolate the AMPAR-mediated component of evoked
responses, we used a pipette solution containing (in mM) 130 K+-
gluconate, 10 HEPES, 10 KCl, 2 MgCl2, 2 ATP-Mg, 0.2 GTP, and
normal ACSF containing the NMDAR antagonist dl-2-amino-
5-phosphonovaleric acid (AP5; 50µM), picrotoxin (50µM), and
CGP 52432 (10µM).
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FIGURE 1 | Excitatory (PCs) and inhibitory (Ints) neurons recorded in
the CA1 region of the hippocampus. (A) CA1 PCs and Ints were
patch-clamped with a pipette solution containing Lucifer Yellow (2 mM). The
location of neurons in the slices was visualized by superimposition of the
reflected light image of the hippocampal slice and of the Lucifer yellow
fluorescence signal (left panel). The right panel shows reconstructed
confocal images of two PCs (yellow) and three Ints (green) recorded in the
CA1 sp and sr, respectively. (B,C) Confocal images of one PC (B) and one
Int (C) of CA1 pyramidal layer and stratum radiatum, respectively. (B) Right
and (C) right expanded confocal images of dendritic spines. Note the spiny
dendritic segment of the PC (B) in contrast with the a-spiny (C) one of the
Int. The arrowheads indicate dendritic spines. (D,E) Voltage responses of
one PC and one Int (top), to a series of intracellular current pulses (bottom)
are shown. The current was applied at rest (−70 and −56 mV for PC and Int,
respectively). Inset, action potentials from a PC and Int are superimposed.
Note the larger Iahp in Int compared to PC. Abbreviations: so, stratum oriens;
sp, stratum pyramidale; sr, stratum radiatum; slm, stratus lacunosum
moleculare. Scale bar: 200µm.
A paired-pulse stimulation paradigm was used to evaluate the
locus of action of memantine. It is known that alterations in the
paired-pulse ratio of evoked post-synaptic currents (EPSCs) fol-
lowing drug application are an indication of a pre-synaptic action
of the drug. We delivered two stimuli with an inter-stimuli inter-
val of 100 ms. The paired-pulses were repeated 30 times with an
interval of 10 s, and then averaged for analysis. The paired-pulse
ratio was determined by dividing the peak amplitude of the second
evoked NMDAR current by the peak amplitude of the first (peak
2/peak 1; Thomson, 2000).
Kinetic analysis was performed on averaged evoked EPSCs
(30 consecutive traces). The rise-times of NMDAR currents
were measured at 10–90%. Their decays were fitted with the
exponential functions: y=Af exp(−t /τf)+As exp(−t /τs) for
double- and y=A1exp(−t /τ) for single exponential decay,
where A is the amplitude, τ is the decay time-constant, and
the subscript f and s denote fast and slow components,
respectively. Weighted time-constants (τmean) were calculated
using the equation: τmean= [Af/(Af +As)]τf + [As/(As+Af)]τs
(Stocca and Vicini, 1998). The dose-response data for meman-
tine on PCs and Ints were fitted with the Hill equation:
Y =Bottom+ [(Top+Bottom)/1+ 10(LogIC50−X)×HillSlope]. The
variable Bottom is the Y value at the bottom plateau (0), Top is
the Y value at the top of the plateau (100), and LogIC50 is the
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X value when the response is halfway between Bottom and Top.
The variable HillSlope (Hill coefficient) describes the steepness of
the curve. Data were collected using pClamp 10 software (Mol-
ecular Devices, Sunnyvale, CA, USA). Analyses were performed
off-line with IGOR software (WaveMetrics, Inc., Lake Oswego, OR,
USA). Statistical significance of the results was determined with
paired Student’s t -tests (two-tailed). All values are expressed as
means± SEM, and a p-value of <0.05 was considered significant.
All drugs were obtained from Sigma-Aldrich (St Louis, MO,
USA), with the exception of NBQX and GCP 52432 which were
purchased from Tocris Bioscience (Minneapolis, MN, USA), and
NVP-AMM077 which was a kind gift from Dr. Yves Auberson
(Novartis, Basel, Switzerland). NVP-AAM077, Ro25-6981, and
memantine were applied until the amplitude of the NMDAR cur-
rents reached a stable plateau. To establish that a plateau for the
effect of memantine was attained (i.e., that equilibrium blockade
was achieved), the average responses of two consecutive record-
ings of 5 min of evoked NMDAR responses needed to display the
same amplitude and shape. For every neuron, memantine was
applied until a plateau was reached. Longer times were required
for low memantine concentrations to attain this plateau (i.e., see
Figure A1 in Appendix for 1µM memantine).
ELECTROPHYSIOLOGICAL AND MORPHOLOGICAL IDENTIFICATION OF
RECORDED CELLS
The electro-responsive properties of PCs and Ints were studied in
current-clamp by applying 1000 ms current pulses from resting
membrane voltage (Vm) in normal ACSF. Whole-cell record-
ings were obtained using pipettes filled with a solution containing
(mM): 130 K+-gluconate, 10 HEPES, 10 KCl, 2 MgCl2, 2 ATP, and
0.2 GTP. The amplitude of current pulses was varied in increments
of 10 pA. The input resistance (Rin) was estimated in the linear
portion of current–voltage plots. The membrane time-constant
(τ) was derived from single exponential fits to voltage responses in
the linear portion of current–voltage relations. The spike ampli-
tude and the spike amplitude at half-duration were measured from
the first action potential evoked by a current pulse.
In some experiments, recorded neurons were identified by
including Lucifer Yellow (2 mM) in the pipette. The slices were
removed from the chamber and fixed for 1–3 days in 0.1 M
phosphate-buffered saline, pH 7.4, containing 4% paraformalde-
hyde. Slices were washed in dimethyl-sulfoxide (DMSO) for 1 h
and visualized with a Fluo-View FV1000 Olympus confocal micro-
scope (Olympus Canada, Inc., Markham, ON, Canada) using 10×
and 40× water immersion objectives. Three-dimensional recon-
structions of the neurons were made from z-series optical sections
using the Olympus FV10-ASW Viewer.
RESULTS
PHYSIOLOGICAL AND MORPHOLOGICAL PROPERTIES OF CA1
PYRAMIDAL CELLS AND Ints
Cells were visually identified in hippocampal slices with IR-DIC
and selected for recordings on the basis of their morphology
and localization in specific layers of the CA1 region (see Mate-
rials and Methods). PCs and Ints were recorded in the pyramidal
layer and stratum radiatum, respectively (Figure 1). A total of
11 Ints and 10 PCs were morphologically identified using Lucifer
Yellow (see Materials and Methods). In the experiments designed
to record Ints in the stratum radiatum, pipettes were positioned
over the ovoid somatic profile. All cells chosen in this way (n= 11)
were found to be Ints with a-spiny, very sparsely spiny, or vari-
cose dendrites (Figure 1C; Freund and Buzsáki, 1996). Whole-cell
recordings were obtained in current-clamp mode to examine the
intrinsic membrane properties of PCs (n= 10) and Ints (n= 11).
The PCs generated spike trains that exhibited frequency adapta-
tion when depolarized (Figure 1D). The Ints could sustain high
firing rates without or with various degrees of accommodation
(Figure 1E). In addition, they had significantly pronounced after-
hyperpolarization (I ahp fast, 10 vs. 2 mV in PCs, p= 0.001; I ahp
slow, 14 vs. 3 mV in PCs, p= 0.00001; Table 1 and Figure 1D
inset) and Ih current (sag at −100 pA current step: 13.5± 1.7 vs.
2.9± 0.4 mV in PCs, p= 0.0007; Figures 1D,E). A summary of
the electrophysiological properties of the PCs and Ints recorded in
this study is provided in Table 1. In Ints, resting membrane poten-
tial (Vm) was significantly more depolarized (−57 vs.−69 mV in
PCs, p= 0.00078), action potential amplitude (spike amplitude)
was significantly smaller (69 vs. 96 mV in PCs, p= 0.00023), and
input resistance (Rin) was significantly larger (457 vs. 96 MΩ in
PCs, p= 0.0000012), while the duration of the action potential
at half-amplitude was not significantly different (1.7 vs. 1.6 ms in
PCs, p= 0.59). These data are in agreement with that previously
reported by Martina et al. (2003).
EFFECT OF MEMANTINE ON NMDAR CURRENTS IN PCs AND Ints
To test the effect of memantine on neurons regulating excitation-
inhibition balance in the hippocampal neuronal circuitry, we
recorded NMDAR currents in PCs and Ints (Figure 2), and mea-
sured the effect of the bath application of memantine at different
concentrations. To evoke post-synaptic glutamatergic currents in
PCs and Ints, the Shaffer collaterals were stimulated with a bipolar
electrode. The NMDAR-mediated component of the post-synaptic
current was pharmacologically isolated atVm=−70 mV in a low
Mg2+ACSF (see Materials and Methods). The isolated NMDAR
currents displayed an averaged amplitude of 57.46± 9.10 pA
(n= 62) in PCs and 28.00± 2.65 pA (n= 54) in Ints. Memantine
attenuated NMDAR current amplitudes in both PCs (Figure 2A)
and Ints (Figure 2B); see Figure 2 legend for percentages of reduc-
tion). Memantine antagonism was concentration-dependent, with
IC50 values of (LogIC50=−5.11) 7.7µM and (LogIC50=−4.77)
17µM for PCs and Ints, respectively (Figure 2C). The two IC50
values were significantly different (p= 0.01326; non-parametric
Wilcoxon Rank Test). In addition to the higher affinity of meman-
tine for NMDARs in PCs vs. Ints, the fitting parameters of the Hill
equation showed significantly different Hill coefficients (see Mate-
rials and Methods) in PCs (Hill coefficient= 0.6101± 0.07) and
Ints (Hill coefficient= 1.106± 0.16;p= 0.0086; Figure 2C). A Hill
coefficient lower than one indicates positive cooperativity, suggest-
ing that the PCs may possess at least two subtypes of NMDAR, one
of which appears to have a higher affinity for memantine, whereas
Ints (negative cooperativity) may express a single NMDA receptor
subtype with a lower affinity for memantine.
To rule out the possibility that these differences were attribut-
able to memantine-mediated changes in neurotransmitter release,
we recorded NMDAR currents in PCs and delivered paired-pulse
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Table 1 | Electrophysiological properties of CA1 PCs and Ints.
Cell type Resting membrane
potentialVm (mV)
R in (MΩ) Spike
amplitude (mV)
Spike duration at
half-amplitude (ms)
τ (ms) Iahp fast
(mV)
Iahp slow
(mV)
PCs n=10 −69.9±0.79 96.6±5.18 96.2±3.33 1.73±0.09 34.9±2.88 1.55±0.51 2.97±0.33
Ints n=11 −56.7±2.72 457±47.58 69.3±3.36 1.65±0.11 28.8±3.23 9.98±1.68 13.9±1.19
FIGURE 2 | Effect of memantine on NMDAR currents in PCs and Ints in
the CA1 region of the hippocampus. NMDAR currents were recorded
from individual PCs and Ints voltage-clamped at V m=−70 mV. (A,B)
Time-course of memantine-induced reduction on the NMDAR current
amplitude in PCs and Ints, respectively. In PCs, bath application of 100 nM,
1µM, 10µM, 20µM, 100µM, 300µM, 500µM, and 1 mM memantine
reduced the amplitude of the NMDAR currents by 0% (n=3),
27.28±13.26% (n=5), 52.66±3.52% (n=14), 60.55±2.93% (n=7),
73.82±3.48% (n=7), 87.8±2.42% (n=8), 98.04±1.69% (n=3), and
100% (n=3), respectively. In Ints, bath application of 100 nM, 1µM,
10µM, 20µM, 100µM, 300µM, 500µM memantine reduced the
amplitude of NMDAR currents by 0% (n=3), 0.5±0.4% (n=7);
48.3±4.98% (n=16), 53.22±8.35% (n=5), 90.85±6.4% (n=4),
98.29±1.7% (n=3), and 100% (n=3), respectively. Normalized NMDAR
current amplitudes (%) are plotted as a function of time for memantine
concentrations of 100 nM (full square), 20µM (empty circle), 300µM (full
circle). Each point (one every min) is the average of six points (stimulations
every 10 s). The bars indicate the duration of memantine exposure.
Mean± sem. (C) Memantine dose-response curve in PCs (black) and Ints
(red), respectively. Error bars represent SD. (D) Examples of traces of
NMDAR currents measured before (a) and after memantine applications
(b) are shown for PCs (black) and Ints (red).
stimulation (100 ms) to the Schaffer collaterals in the absence
and presence of memantine (10 and 300µM; see Materials and
Methods). In the absence and presence of memantine (10 and
300µM) the second response showed facilitation. The evoked
currents had peak 2/peak 1 ratios of 2.32± 0.15 (n= 8) in the
absence of memantine and did not change in presence of meman-
tine at 10µM 2.24± 0.07 (n= 4) and 300µM 2.12± 0.09 (n= 4),
respectively (Figure A2 in Appendix). These values were not sig-
nificantly different (p= 0.69 and p= 0.36 for 10 and 300µM
memantine, respectively), demonstrating that memantine does
not alter neurotransmitter release by acting on pre-synaptic
afferents.
To further explore the possibility of a memantine effect on neu-
rotransmitter release we used the NMDA open-channel blocker
MK-801. Rosenmund et al. (1993) showed that the rate of progres-
sive MK-801 block of NMDAR currents reflects the probability of
pre-synaptic neurotransmitter release. If the probability of release
is high, more terminals will release neurotransmitter, more post-
synaptic NMDAR channels will open, and the MK-801 progressive
block will be more rapid. Consistent with this hypothesis, we
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measured the progressive MK-801 (5µM) block of NMDAR cur-
rents before and after application of memantine (10µM) in PCs
and Ints to estimate the effect of memantine on the probability of
pre-synaptic release. NMDAR currents were evoked every 5 s and
MK-801 time-course measured by the fitting of a single exponen-
tial [y=A1exp(−t /τ)] of the NMDAR current peak amplitude
plotted against stimulation number (Figure A3 in Appendix). The
MK-801 block rate was 250 stimuli in PCs (n= 8) and 318 stimuli
in Ints (n= 7), suggesting a higher probability of release in PCs
compared to Ints (Figure A3 in Appendix). This is not surprising
considering that the non-uniform size and structure of synaptic
terminals in the central nervous system results in variable proba-
bilities of release at terminals within a single synapse, and is not
the same for different terminals on different types of neurons.
Next, memantine (10µM) was applied until NMDAR currents
attenuated to a plateau, then MK-801 was co-applied (Figure A3
in Appendix). The block rate of MK-801+memantine was 214
stimuli in PCs (n= 4) and 275 stimuli in Ints (n= 8). These values
were not significantly different from those obtained with MK-801
alone (PCs: p= 0.35; Ints: p= 0.91). These results support the
previous finding that memantine had no effect on pre-synaptic
release probability.
To ensure that the observed effects of memantine were
specific to NMDARs, we evoked AMPAR currents in the
absence and presence of memantine (10µM; see Materials
and Methods). Evoked AMPAR currents had an activation
time-constant of 2.47± 0.73 ms and a deactivation kinetic of
20.18± 2.7 ms (n= 4). After 25 min of continuous memantine
exposure, the activation time-constant (2.38± 0.54 ms), the deac-
tivation kinetic (21.60± 2.7 ms,n= 4), and the current amplitude
(51.42± 13.33 pA control, 53.75± 12.6 pA memantine, n= 4;
Figure A4 in Appendix) did not change significantly (p= 0.9).
These observations indicate that memantine’s effects were limited
to NMDAR currents on Schaffer collateral-CA1 synapses.
The primary binding site of memantine on NMDARs over-
laps that of Mg2+ (Kashiwagi et al., 2002; Chen and Lipton,
2005), however, memantine is thought to act as a more effective
surrogate for the divalent Mg2+ (Parsons et al., 2007). In the hip-
pocampal network, the Shaffer collaterals release glutamate that
generates post-synaptic currents (PSCs), which depend largely on
the activation of AMPARs. AMPARs depolarize the post-synaptic
membrane causing the Mg2+ block to be relieved and NMDARs
to open.
To study the effect of memantine on NMDAR currents in PCs
and Ints in physiological Mg2+, we recorded NMDAR-mediated
component of the post-synaptic current as described above but
in normal ACSF (see also Materials and Methods). The neurons
were held at −30 mV to release the Mg2+ block and memantine
was added to the bath solution at different concentrations. The
cells were depolarized to−30 mV since, in the NMDAR IV curve,
the larger inward NMDAR currents are evoked at this potential
(Nowak et al., 1984). As in low Mg2+ ACSF, memantine attenuated
NMDAR current amplitudes in both PCs and Ints (Figure 3). In
PCs, bath application of 100 nM, 1µM, 10µM, 100µM, 300µM,
500µM, and 1 mM memantine reduced the amplitude of the
NMDAR currents 0.7± 1.15% (n= 4), 22.73± 2.66% (n= 4),
60.97± 9.72% (n= 4), 77.15± 4.77% (n= 5), 97.52± 0.63%
(n= 2), 100% (n= 3), and 100% (n= 3), respectively. In Ints, bath
application of 100 nM, 1µM, 10µM, 100µM, 300µM, 500µM,
and 1 mM memantine reduced the amplitude of the NMDAR cur-
rents 0% (n= 3), 5.48± 3.09% (n= 4); 38.97± 6.96% (n= 7),
76.70± 3.38% (n= 4), 91.99± 2.80% (n= 5), 100% (n= 3);
100% (n= 3). As in low Mg2+ ACSF, memantine antagonism was
concentration-dependent in both PCs and Ints. At −30 mV in
presence of Mg2+, IC50 values were (LogIC50=−5.37) 4.2µM
and (LogIC50=−4.64) 22.45µM for PCs and Ints, respectively,
further supporting a higher affinity of memantine for PCs’
NMDAR currents. The two IC50 values were significantly different
(p= 0.000232; non-parametric Wilcoxon Rank Test).
In addition to the higher affinity of memantine for NMDARs
in PCs vs. Ints, the fitting parameters of the Hill equation showed
significantly different Hill coefficients (see Materials and Meth-
ods) in PCs (Hill coefficient= 0.617± 0.02) and Ints (Hill coeffi-
cient= 0.879± 0.08; p= 0.003; Figure 3). Hill coefficients lower
than one indicate positive cooperativity, suggesting that, in the
virtual absence of Mg2+,both PCs and Ints possess at least two sub-
types of NMDAR; in contrast, the Hill coefficient values obtained
in presence of Mg2+ suggested that Ints (negative cooperativity)
may express a single NMDA receptor subtype with a lower affinity
for memantine.
MOLECULAR MAKE-UP OF NMDARs IN PCs AND Ints
N -Methyl-d-aspartate receptor are composed of NR1 and NR2
subunits. The expression of NR1/NR2A subunits produces
channels with faster deactivation (tens of milliseconds) than
NR1/NR2B or NR1/NR2C (hundreds of milliseconds; Stocca and
Vicini, 1998), whereas the NMDARs containing NR1/NR2D sub-
units display very slow kinetics (seconds; Stocca and Vicini, 1998;
Misra et al., 2000). In the hippocampus PCs express mainly NR2A
and NR2B subunits, while Ints have a larger percentage of NR2C
and NR2D subunits (Monyer et al., 1994; Martina et al., 2003). To
verify the difference in subunit composition in the two types of
neurons, we observed the biophysical properties of the NMDAR
currents in PCs and Ints. The NMDAR current decay in both PCs
and Ints was best-fitted with a bi-exponential function (Figure 4).
The best-fitted decay values for PCs and Ints are shown in Table 2.
The values of τdeact f and τdeact s between PCs and Ints were not
significantly different. However, the difference in relative portions
(Af and As) of decay time-constants in PCs and Ints was signif-
icant and hence the τmean (Table 2; see Materials and Methods),
confirming the different molecular make-up of NMDARs in PCs
and Ints.
EFFECT OF MEMANTINE ON NVP-AAM077- AND Ro25-6981-RESISTANT
NMDAR CURRENTS IN PCs AND Ints
To determine the effect of memantine on different components
of NMDAR currents, we recorded currents in presence of the
NR2B-containing NMDARs antagonist Ro25-6981 (500 nM; Fis-
cher et al., 1997) and the NR2A-containing NMDARs antag-
onist NVP-AAM077 (50 nM; Auberson et al., 2002; Weitlauf
et al., 2005). NMDAR currents were evoked every 10 s by releas-
ing pre-synaptic glutamate via electrical stimulation and the
antagonists were added to the bath solution via perfusion (see
above).
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FIGURE 3 | Effect of memantine on NMDAR currents recorded in
presence of Mg2+ atVm =−30, in PCs and Ints in the CA1 region of
the hippocampus. (A–C)Time-course of memantine-induced
reduction on the NMDAR current amplitude in PCs and Ints,
respectively. Normalized NMDAR current amplitudes (%) are plotted as
a function of time for memantine concentrations of 100 nM (full
square), 10µM (empty circle), 300µM (full circle). Each point (one
every min) is the average of six points (stimulations every 10 s). The
bars indicate the duration of memantine exposure. Mean± sem. (B,D)
Memantine dose-response curve for PCs (B) and Ints (D) in absence
(full black circle; same data as in Figure 2C) and presence (empty red
circle) of physiological concentration of Mg2+ respectively. (E)
Summary of the memantine dose-response curve in PCs (black) and
Ints (red), in normal ACSF. Error bars represent SD. (F) Examples of
traces of NMDAR currents measured before and after memantine
applications are shown for PCs (black) and Ints (red).
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Ro25-6981 is a potent and selective activity-dependent blocker
of NMDARs containing the NR2B subunit. IC50 values are
0.009 and 52µM for cloned receptor subunit combinations
NR1C/NR2B and NR1C/NR2A, respectively (Fischer et al., 1997).
However, NR2B antagonists are influenced by Mg2+ concentra-
tion and NR2B-directed NMDAR antagonists in the hippocampal
slice are more potent in the absence of Mg2+ (Williams, 1993;
Mott et al., 1998; Rauner and Köhr, 2011). Consequently, in
this experimental series, NMDAR currents were recorded in the
virtual absence of Mg2+ (low Mg2+ ACSF). Under these condi-
tions, Ro25-6981 (500 nM) reduced the amplitude of the NMDAR
currents by 24.45± 6.71% (n= 9) in PCs and by 35.07± 6.98%
(n= 8) in Ints, respectively (Figure 6A).
NVP-AAM77 is a competitive antagonist of NR2A-containing
NMDARs. It has been shown that for glutamate-evoked currents,
FIGURE 4 | NMDAR deactivation kinetics in PCs and Ints. (A,B)
Examples of traces of NMDAR currents measured before (control, thin line)
and after memantine (10µM; thick line) application are shown for PCs and
Ints, respectively. NMDAR currents were recorded from individual PCs and
Ints voltage-clamped at V m=−70 mV. Each trace is an average of 30
acquisitions. (C) Decay time-course of NMDAR currents recorded in PCs
(black line) and Ints (red line). The traces are normalized to the amplitude.
Blue dotted line: fitting of the deactivation kinetics of NMDAR currents.
Note that the decay of the NMDAR currents in Ints (red line) was slower
than that of PCs (black line).
the IC50 values for NVP-AAM077 acting at NR1/NR2A and
NR1/NR2B NMDA receptors were 16± 2 nM (NR1/NR2A) and
302± 18 nM (NR1/NR2B; Frizelle et al., 2006), respectively. NVP-
AAM077 (50 nM) reduced the amplitude of the NMDAR currents
by 45.5± 3.40% (n= 7) in PCs and by 21.00± 9.49% (n= 7) in
Ints, respectively. However, caution is warranted when interpret-
ing NVP-AAM077 data since NVP-AAM077 (400 nM) has been
reported to target non-NR2A-containing NMDARs when applied
30 min prior to an agonist (Weitlauf et al., 2005). However, if
antagonism of NVP-AAM077 on NMDAR currents is similar at
50 and 400 nM, then the specificity of NVP-AAM077 for NR2A
was conserved under the experimental conditions employed here.
Bath application of NVP-AAM077 (400 nM) reduced the ampli-
tude of the NMDAR currents by 50.54± 3.90% (n= 15) in PCs
and by 21.50± 16.3% (n= 8) in Ints, respectively. The plateau
effect of NVP-AAM077 at 50 and at 400 nM was reached after
10 min of perfusion (see Figure 6A) and remained constant, indi-
cating that NVP-AAM077’s specificity for NR2A was conserved
even at 400 nM. The reductions in current caused by NVP-
AAM077 (400 nM) and (50 nM) were not significantly different
(p= 0.223 for PCs and p= 0.428 for Ints), suggesting that only
NR2A-containing NMDARs were antagonized by NVP-AAM077.
The difference in the percentage of NMDARs containing the
NR2A and NR2B subunit in PCs and Ints (Monyer et al., 1994;
Martina et al., 2003) can also account for the faster deactivation
decay observed in PCs (Figure 4C; see Discussion).
We then applied memantine and measured its effect on differ-
ent components of NMDARs (Figure 5E). Memantine was used
at 10µM since this concentration was close to the IC50 for PCs
and Ints.
In the presence of NVP-AAM077, the residual NMDAR cur-
rents (see decay time-constants in Tables 3 and 4) were reduced
by memantine by 42.02± 4.13% (n= 15; in the presence of
400 nM NVP-AAM077) and 42.90± 3.54% (n= 7; in the pres-
ence of 50 nM NVP-AAM077) in PCs and by 64.76± 2.76% (n= 8
in the presence of 400 nM NVP-AAM077) and 58.00± 9.96%
(n= 5; in the presence of 50 nM NVP-AAM077) Ints, respec-
tively (Figures 5A–D). The values for NVP-AAM077 used at 400
and 50 nM were not significantly different (p= 0.442 for PCs and
p= 0.258 for Ints), while the differences between PCs and Ints
were (400 nM: p= 0.026; 50 nM: p= 0.039).
In the presence of Ro25-6981, the residual NMDAR currents
(see decay time-constants in Tables 3 and 4) were reduced by
memantine by 61.49± 7.04% (n= 9) and 33.77± 5.91% (n= 8)
in PCs and Ints, respectively (Figures 5B,C). The difference
between PCs and Ints was significantly different (p= 0.0047).
Table 2 | Decay time-constants of the NMDAR currents in PCs and Ints.
τdeact f (ms) τdeact s (ms) Af (%) As (%) τmean (ms)
PCs n=62 54.75±2.02 493±57.76 79.36±1.97 20.64±1.97 130.6±11.80
Ints n=54 69.14±9.26 470±73.50 57.95±3.63* 42.05±3.63* 206.6±25.05*
Values are means± sem. Electrically evoked NMDAR currents were recorded in low Mg2+ ACSF (0.1 mM) in the presence of picrotoxin (50µM), NBQX (20µM), and
CGP 52432 (10µM). The fast and the slow components of the deactivation kinetics are designed by f and s, respectively. *Indicates a significant difference between
the indicated values and their controls (Af, p=6.3e−08; As, p=6.3e−08; τmean, p=0.0016).
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Table 3 | Decay time-constants of the NVP-AAM077-, Ro25-6981, and NVP-AAM077+Ro-6981-resistant NMDAR currents in PCs.
τdeact f (ms) τdeact s (ms) Af (%) As (%) τmean (ms)
NVP-AAM077
n=18
74.27±5.17 514±86.69 70.56±1.87 29.44±1.97 187.6±5.09
Ro25-6981
n=9
60.84±5.65 382±40.32 86.88±2.25 13.12±2.25 97.3±6.89*
NVP-AAM077
and Ro25-6981
n=4
84.78±5.56 592±65.04 70.56±3.12 29.43±3.12 237.3±2.45*
Values are means± sem. Electrically evoked NMDAR currents were recorded in low Mg2+ ACSF (0.1 mM) in the presence of picrotoxin (50µM), NBQX (20µM) and
CGP 52432 (10µM).The fast and the slow components of the deactivation kinetics are designated by f and s, respectively. *Indicates a significant difference between
the indicate values and their controls (τmean Ro25-6981 vs. NVP-AAM077, p= 0.002; τmean NVP-AAM077+Ro25-6981 vs. NVP-AAM077, p=0.002).
Table 4 | Decay time-constants of the NVP-AAM077-, Ro25-6981, and NVP-AAM077+Ro-6981-resistent NMDAR currents in Ints.
τdeact f (ms) τdeact s (ms) Af (%) As (%) τmean (ms)
NVP-AAM077
n=8
77.70±17.7 422±43.55 56.08±6.25 43.92±6.25 233.5±36.5
Ro25-6981
n=9
79.6±21.73 564±58.50 60.23±8.52 39.72±8.52 237.1±34.04
NVP-AAM077
and Ro25-6981
n=8
81.53±19.9 542±48.71 68.7±6.94 31.31±6.94 239.2±22.35
Values are means± sem. Electrically evoked NMDAR currents were recorded in low Mg2+ ACSF (0.1 mM) in the presence of picrotoxin (50µM), NBQX (20µM), and
CGP 52432 (10µM). The fast and slow components of the deactivation kinetics are designated by f and s, respectively.
To further explore the specific effects of memantine on the
NR2C and 2D subunit component of NMDARs in PCs and
Ints, we co-applied NVP-AAM077 and Ro25-6981. This reduced
NMDAR current amplitudes by 74.81± 3.11% (n= 4) in PCs and
62.18± 4.16% (n= 8) in Ints (Figure 6). The subsequent applica-
tion of memantine (10µM) further reduced the residual NMDAR
currents by 27.76± 7.67% (n= 4; p= 0.0429) and 28.43± 6.79%
(n= 8; p= 0.018) in PCs and in Ints, respectively (Figures 5C
and 6).
DISCUSSION
Our results show that in the CA1 region of the rat hippocampus,
memantine antagonism on synaptically evoked NMDAR currents
is more robust in PCs than in Ints. We report that this selective
antagonism is attributable to specific differences in the molecular
make-up of the NMDARs in excitatory and inhibitory neurons
(Figure 7).
A CA1 PC receives about 30000 synaptic inputs. The cell body
integrates inputs from the dendrites and receives only GABAergic
synapses, as does the axon-initial segment, which contributes to
action potential generation. The small, oblique dendrites emerg-
ing from one or two large apical dendrites and the basal dendrites
receive glutamatergic inputs mainly from the hippocampal CA3
area, local axon collaterals, and the amygdala. The apical den-
dritic tuft is innervated mainly by glutamatergic inputs from the
entorhinal cortex and the thalamus. All dendrites also receive
local GABAergic inputs from Ints. Such a compartmentalized
structure of PCs allows spatially segregated activities at the same
time (Klausberger and Somogyi, 2008).
Multiple subtypes of Ints have been described in the hippocam-
pus (Freund and Buzsáki, 1996; Klausberger, 2009; Kullmann,
2011). In this study, recordings were obtained from PCs and Ints in
the stratum pyramidale and stratum radiatum of the CA1 region
of the hippocampus, respectively (Figure 1). We recorded from
Ints in the stratum radiatum of the CA1 region because of their
well-described morphology, electrophysiological characteristics,
and connectivity (Freund and Buzsáki, 1996; Morin et al., 1996;
Parra et al., 1998). Following the interneuron classification (Klaus-
berger, 2009), we suggest that the Ints we recorded were Schaffer
collateral-associated cells and/or apical dendrite innervating cells
which express cholecystokinin (i.e., CCK-expressing Ints; Klaus-
berger, 2009). It has been hypothesized that CCK-expressing Ints
firing during ripple and theta oscillations might indicate a role in
shaping the activity of subgroups and assemblies of PCs instead
of synchronizing the entire network (Klausberger et al., 2005).
CA1 hippocampal Ints receive two types of excitatory inputs:
feedback and feed-forward (Schwartzkroin and Mathers, 1978;
Lacaille et al., 1987; Kullmann, 2011), depending on their sub-
type and location. Notably, in the stratum radiatum of the CA1,
glutamatergic inputs to Ints are predominantly from local collater-
als of PCs or Schaffer collateral fibers (Freund and Buzsáki, 1996;
Kullmann, 2011). The CA3 input to CA1 PCs, mediated by the
Schaffer collaterals, is glutamatergic (Amaral and Witter, 1989).
Ints that appear to be specialized to mediate feed-forward signaling
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FIGURE 5 | Effect of memantine on NVP-AAM077- and
Ro25-6981-resistent NMDAR currents in PCs and Ints. NMDAR currents
were recorded from individual PCs and Ints voltage-clamped at V m=−70 mV.
(A,B)Time-course of the NVP-AAM077, Ro25-6981 memantine-induced
reduction on NMDAR current amplitude in PCs (empty circle) and Ints (full
circle). Normalized NMDAR current amplitudes (%) are plotted as a function
of time. Each point (one every min) is the average of six points (stimulation
every 10 s). The bars indicate the duration of drug application. (C,D) Examples
of traces of NMDAR currents recorded in PCs (top) and Ints (bottom). Each
trace is an average of 30 traces. (E) Histogram showing the effect of
memantine (10µM) in PCs and Ints in control (black), in presence of
Ro25-6981 (dashed lines), in presence of NVP-AMM077 (white), and in
presence of NVP-AMM077+Ro25-6981 (gray). The magnitude of the
memantine effect was measured after 25 min of exposure.
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FIGURE 6 | Effect of memantine on NMDAR currents in PCs and Ints
resistant to co-application of NVP-AAM077 and Ro25-6981. NMDAR
currents were recorded from individual PCs and Ints voltage-clamped at
V m=−70 mV. (A)Time-course of the NVP-AAM077, Ro25-6981
memantine-induced reduction on NMDAR current amplitude in PCs (empty
circle) and Ints (full circle). Normalized NMDAR current amplitudes (%) are
plotted as a function of time. Each point (one every min) is the average of 6
points (stimulation every 10 s). The bars indicate the duration of drug
application. (B) Examples of traces of NMDAR currents recoded in PCs (top)
and Ints (bottom). Each trace is an average of 30 traces.
are often referred to by the identity of the afferent projection that
excites them or by the location of their cell bodies. This nomencla-
ture may conceal considerable heterogeneity. Nevertheless, some
interesting principles have emerged in recent years (Kullmann,
2011). It appears that NMDAR-mediated pathway specificity is
expressed in excitatory neurons but not in inhibitory neurons
(Kumar and Huguenard, 2003), and NMDARs underlying excita-
tory inputs onto an inhibitory neuron are most likely homogenous
(Maccaferri and Dingledine, 2002). Hence, there may be far more
inhibitory neurons than excitatory neurons that can be classified
as being distinct based solely on the type of NMDARs they express
(Lei and McBain, 2002).
We report that memantine preferentially antagonizes NMDAR
currents in PCs over Ints, as indicated by the IC50 values for these
two types of neurons (PCs: absence of Mg2+ 7.7µM, presence of
Mg2+ 4.2µM; Ints: absence of Mg2+ 17µM, presence of Mg2+
22.45µM). Hill coefficients calculated in presence and virtual
absence of Mg2+, from the sigmoid dose-response curves for these
two types of neurons suggest that, in presence of Mg2+, PCs may
possess at least two subtypes of NMDAR, one of which appears to
have a higher affinity for memantine, whereas Ints may express a
single NMDA receptor subtype with a lower affinity for meman-
tine. In contrast, in the virtual absence of Mg2+, both PCs and
Ints Hill coefficients, even if significantly different, suggest pos-
itive cooperativity. This discrepancy may be due to the fact that
different types of NMDAR subtypes show different Mg2+ and
voltage sensitivity.
In the hippocampus, PCs mainly express NR2A and NR2B sub-
units, while Ints have a larger percentage of NR2C and NR2D
subunits (Monyer et al., 1994; Martina et al., 2003). We stud-
ied the molecular make-up of the native NMDARs using phar-
macological tools and found that NMDARs in PCs contained
∼50% NR2A, ∼25% NR2B, and ∼25% NR2C-D, while Ints
contained ∼20–25% NR2A,∼35% NR2B, and ∼40–45% NR2C-
D (Figure 7A), accounting for the different NMDAR kinetics
observed in PCs and Ints. Very recently, it has been reported
(Rauner and Köhr, 2011) that triheteromeric NR1/NR2A/NR2B
receptors constitute the majority of the NMDAR population
in adult rat hippocampus synapses and that antagonists such
as Ro25-6981 are NR2B-directed but not NR1/NR2B-selective
antagonists. In NR1/NR2A/NR2B receptors, the NR2B subunit
slows deactivation kinetics, whereas the presence of NR2A con-
fers voltage-dependence of decay. Consequently, a percentage of
the NMDAR current reduction by Ro25-6981 that we observed
could be due to antagonism at the NR1/NR2A/NR2B receptor,
as well as at the NR1/NR2B receptor. Nevertheless, the differ-
ences in NMDAR kinetics in PCs and Ints reported in this
study are attributable to neurons with different NMDAR subunit
composition.
It has previously been proposed that memantine is relatively
selective for NR2B. This is partially supported by the finding that
memantine is three times more potent against NMDA-induced
Ca2+ influx in human NR1a/NR2B receptors than in human
NR1a/NR2A expressed in L(tk-) cells (Grimwood et al., 1996).
However, these data are controversial, since different types of cells
transfected with different types of NMDAR subunits showed dif-
ferent IC50 values: in oocytes NR2A 0.89µM, NR2B 0.40µM,
NR2C 0.32µM, and NR2D 0.28µM (Parsons et al., 1999), and
NR2A 0.29µM, NR2B 0.23µM (Avenet et al., 1997); in HEK-
293 cells, NR2A 0.93µM, NR2B 0.82µM, and NR2D 0.47µM
(Bresink et al., 1996).
In this study, in PCs, in the presence of NVP-AAM077, meman-
tine reduced NMDAR currents (NR2B, C-D: 50% of the total
NMDAR current) by ∼42%, while in presence of R025-8169,
memantine reduced the NMDAR currents (NR2A, C-D: 75%
of the total NMDAR current) by ∼62%. Since, in the pres-
ence of NVP-AAM077 and Ro25-6981, memantine attenuated
the residual NMDAR currents containing only the NR2C-D sub-
units by 28%, we conclude that in PCs memantine efficacy is
NR2A>NR2B>NR2C-D. This is also true for Ints (Figure 7).
We found the same effect of memantine on NMDARs contain-
ing NR2C-D in PCs and Ints. Consequently, we conclude that
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FIGURE 7 | (A) Graphical description of the NMDAR subunit composition of
PCs and Ints in the CA1 region of the rat hippocampus. (B) Graphical
representation of the effect of 1µM memantine on the NMDAR currents in
PCs and Ints. The percentage of NMDAR currents blocked by memantine is
represented in yellow. Note that for clarity the values are shown without
standard deviation.
memantine antagonism depends on the molecular make-up of
NMDARs expressed in different neuronal types.
At physiological Mg2+ concentrations (1 mM), it has been
reported that memantine inhibition decreases nearly 20-fold at
resting membrane potential for NR1/NR2A and NR1/NR2B recep-
tors, while the effect on NR1/NR2C and NR1/NR2D decreases
only threefold (Kotermanski and Johnson, 2009). However, in the
hippocampal network at resting membrane potential the num-
ber of open NMDARs is extremely low (Martina et al., 2003).
Indeed, the Mg2+ block of NR1/NR2A subunits and NR1/NR2B
receptors is nearly complete at typical resting membrane volt-
ages, and is relieved upon depolarization. PSCs are generated by
glutamate liberated from the Shaffer collaterals and PSCs depend
largely on the activation of AMPARs. AMPARs depolarize the post-
synaptic membrane, causing the Mg2+ block to be relieved and
NMDARs to open. Our experiments, in the presence of phys-
iological Mg2+ (1 mM) at −30 mV and in the virtual absence
of Mg2+ at −70 mV, show that in PCs, NMDARs have a higher
affinity for memantine at −30 mV (Mg2+ block is relieved by
depolarization; IC50= 4.2µM) than at −70 mV (IC50= 7.7µM;
p= 0.03, non-parametric Wilcoxon Rank Test). In contrast, in
Ints, NMDARs show no significant difference (p= 0.223, non-
parametric Wilcoxon Rank Test) in the affinity for memantine at
−70 mV (IC50= 17µM) and −30 mV (IC50= 22.45µM). These
results further support our findings of variable antagonism of
NMDARs in PCs and Ints under physiological stimulation. We
suggest that the higher affinity of memantine for NMDARs in
PCs is due to the higher percentage of NR2A in PCs compared
to Ints. Clarke and Johnson (2008) demonstrated that the activ-
ity of NMDARs composed of NR1 and NR2B subunits (NR1/2B
receptors) is enhanced by depolarization even in 0 Mg2+. Col-
lectively, our findings and those of Kotermanski and Johnson
(2009) support our hypothesis that memantine acts differently on
NMDARs with different subunit composition. It has been shown
that in freshly dissociated rat hippocampal neurons, memantine
(10µM) selectively antagonized NMDA (500µM+ glycine 5µM)
-induced inward currents in a voltage-dependent manner with
an IC50= 1.04± 0.26µM (Parsons et al., 1996). This discrepancy
with our data is probably due to the fact that here we recorded from
only synaptic NMDAR activated by glutamate, while Parsons et al.
(1996) activated synaptic, extra-synaptic, and somatic NMDARs
using NMDA.
The glutamatergic system and, in particular, the NMDAR,
plays an important role in the pathogenesis of numerous neu-
rodegenerative disorders. However, the development of NMDAR
antagonists as therapeutic agents has been disappointing because
of side-effects caused by these drugs. Efforts have been directed
toward low-affinity uncompetitive open-channel (use-dependent)
blockers like memantine which are better suited for therapeu-
tic intervention during excessive NMDAR activation, since their
antagonism requires prior activation of the receptor. In a review
of NMDAR pharmacology Parson and colleagues stated “too lit-
tle activation is bad, too much is even worse” (Parsons et al.,
2007). One approach to avoiding these caveats is to target spe-
cific NMDAR subtypes to restore balance between excitation
and inhibition in the brain and maintain a therapeutic margin
of safety. Although our studies were performed using juvenile
rats, it is of value to consider extrapolation of these observa-
tions to memantine action on neuronal network activities in AD.
The extracellular concentration of memantine in the brains of
AD patients during clinical treatment has been estimated to be
between 0.5 and 1µM (Parsons et al., 2007). It may be thera-
peutically relevant to consider that, at these concentrations, our
dose-response curve indicates that only NMDAR currents in PCs
would be attenuated. It has been suggested that in animal mod-
els of AD, the excitation-inhibition balance in hippocampal cir-
cuitry is shifted toward over-excitation (Schmitt, 2005), and that
dysfunction of inhibitory Ints are likely to increase synchrony
among excitatory principal cells and contributes to the desta-
bilization of neuronal networks (Palop and Mucke, 2010). At a
concentration of 1µM, memantine would reduce PC excitation
of the hippocampal network without attenuating Int inhibition
(Figure 7B). However, at higher concentrations (>10µM), the
antagonism of memantine on PCs and Ints is similar, conferring
no beneficial effect of memantine on the excitatory-inhibitory
balance.
It has been hypothesized that memantine is selective for extra-
synaptic NMDAR receptors (Chen et al., 1998; Lipton, 2007;
Xia et al., 2010). Extra-synaptic receptors may become acti-
vated when glutamate spills out of the synapse during prolonged
depolarization or when glutamate transporters reverse opera-
tion (Jabaudon et al., 2000). However, it has also been suggested
that the most important determinant of memantine selectivity –
synaptic vs. extra-synaptic – is not dependent on the NMDAR
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localization but on the pattern of receptor activation (Wroge
et al., 2012). Wroge et al. (2012) suggest that, at low meman-
tine concentrations, transient receptor activation during brief
transmitter presence limits the amount of memantine channel
block during synaptic activation. By contrast, sustained activa-
tion of receptors facilitates memantine inhibition (Wroge et al.,
2012). Moreover, Danysz and Parsons (2012) suggest that the
most important factors for the action of memantine on synap-
tic vs. extra-synaptic receptor is the resting membrane poten-
tial of the neuron and the NMDA ligand and voltage gating
properties. They suggest that the NMDAR voltage dependency
can be a burden in chronic disease states such as those occur-
ring in AD. Factors that disturb the normal resting membrane
potential of neurons can have severe impact on the normal func-
tion of NMDA receptors as these can lead to a tonic relief of
their voltage-dependent modulation by Mg2+ (Danysz and Par-
sons, 2012). In this context, our quantification of the memantine
effects on synaptic evoked NMDAR current in the two main
neuronal populations (glutamatergic and GABAergic) is impor-
tant to future consideration of in vitro assessment of pharmacolog-
ical efficacy and relevance to physiological or pathophysiological
situations.
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APPENDIX
FIGUREA1 |Time-course of memantine (1µM)-induced reduction on
the NMDAR current amplitude in PCs (empty circle, n=5) and Ints (full
circle, n=3), respectively. Each point (one every min) is the average of six
points (stimulations every 10 s). The bars indicate the duration of
memantine exposure. Mean± sem.
FIGUREA2 | Effect of memantine on paired-pulse stimulation.
(A) Responses were evoked by bipolar electrical stimuli at
V m=−70 mV in PCs. Two pulses of identical intensity were delivered
with an interval of 100 ms. NMDAR evoked responses observed in
control (thin line) and during application of memantine (300µM; thick
line) are superimposed. Each trace is an average of 30 traces.
(B) Histogram of the ratio between the amplitude of the second (P2)
and the first (P1) evoked response in absence (control) and in presence
of memantine (10 and 300µM), is shown. The differences were not
statistically significant (see text).
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FIGUREA3 | Effect of memantine on pre-synaptic probability of release.
(A–C)Time-course of MK-801 (5µM) induced reduction of the NMDAR current
amplitude in PCs (n=8) and Ints (n=7), respectively. NMDAR currents were
recorded from individual PCs and Ints voltage-clamped at V m=−70 mV.
(B,D)Time-course of MK-801 (5µM)+memantine (10µM) induced reduction
of the NMDAR current amplitude in PCs (n=4) and Ints (n= 8), respectively.
Normalized NMDAR current amplitudes (%) are plotted as a function of
number of stimuli. NMDAR responses were evoked every 5 s. The bars
indicate the duration of drug application. The time-courses were obtained by
fitting the curves with a single exponential [y=A1exp(−t /τ)] (solid bold lines).
FIGUREA4 |Time-course of the effects of memantine on AMPAR
currents in PCs. AMPAR currents were recorded from individual PCs
voltage-clamped at V m=−70 mV. Normalized AMPAR current amplitudes
(%) are plotted as a function of time. Each point (one every min) is the
average of six points (stimulations every 10 s). The bars indicate the
duration of memantine exposure. Examples of traces of AMPAR currents
measured before (a) and after memantine (b) application are shown for a
PC. Each trace is an average of 30 acquisitions.
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